GlassScriptPhysician profile
William B Telle
NPI 1942267984
$1,374.41
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $182 · 2021: $301 · 2022: $240 · 2023: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $270.40 | 2019-2022 | |
| Astellas Pharma US INC | $219.66 | 2019-2023 | Myrbetriq |
| Pfizer INC. | $130.32 | 2019-2023 | |
| Boston Scientific Corporation | $101.16 | 2019-2023 | Rezum Generator |
| Axonics, INC. | $63.74 | 2021-2023 | Axonics |
| Antares Pharma, INC. | $62.69 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $50.64 | 2021 | |
| Blue Earth Diagnostics | $49.47 | 2019 | |
| Coloplast Corp | $47.78 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $37.89 | 2023 | Keytruda, Lynparza |
| C. R. Bard, INC. & Subsidiaries | $29.26 | 2020 | |
| Myovant Sciences INC. | $28.53 | 2021 | |
| Accord Healthcare, INC. | $26.50 | 2022-2023 | |
| Urovant Sciences INC | $25.03 | 2022 | |
| Sun Pharmaceutical Industries INC. | $22.45 | 2023 | Yonsa |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.06 | 2023 | |
| Duchesnay USA Incorporated | $20.88 | 2019 | |
| Genzyme Corporation | $20.15 | 2022 | |
| Progenics Pharmaceuticals, INC. | $20.12 | 2022 | |
| Endo Pharmaceuticals INC. | $18.89 | 2023 | Aveed, Xiaflex |
| Dendreon Pharmaceuticals LLC | $18.69 | 2020 | |
| Medtronic, INC. | $17.65 | 2023 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $16.95 | 2019 | |
| Janssen Scientific Affairs, LLC | $15.66 | 2020 | |
| Urogen Pharma, INC. | $13.22 | 2021 | |
| Abbvie INC. | $13.12 | 2023 | Lupron Depot |
| Neotract INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Telle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.